Rapid Assessment of Preterm Labour Risk with Rapid fFN® 10Q
Rapid fFN® 10Q is an in vitro diagnostic test designed for the quantitative detection of fetal fibronectin (fFN) in cervicovaginal secretions. This test is a crucial tool for rapidly assessing the risk of preterm birth in pregnant women with signs and symptoms of preterm labour. The test is particularly useful for patients with intact amniotic membranes and minimal cervical dilation (<3 cm), sampled between 22 weeks, 0 days and 35 weeks, 6 days of gestation.
Rapid fFN® 10Q is indicated for use as an aid in the rapid assessment of the risk of preterm birth in less than 34 weeks, 0 days of gestation in pregnant women with signs and symptoms of preterm labour, intact amniotic membranes, and minimal cervical dilation (<3 cm), sampled between 22 weeks, 0 days and 33 weeks, 0 days of gestation. In addition, it is indicated for assessing the risk of preterm birth at <30 weeks, <34 weeks, and <37 weeks of gestation in pregnant women at risk of preterm birth, sampled between 22 weeks, 0 days and 27 weeks, 6 days of gestation.
Women at risk of preterm labour include patients with a history of preterm labour or preterm rupture of membranes before 37 weeks, a history of spontaneous miscarriage in the second trimester, a history of cervical surgery such as LLETZ, LEEP, laser excision or conisation, and incidental discovery of a cervical length of 25 mm or less during the current pregnancy. These conditions may indicate an increased risk of complications during pregnancy, requiring careful monitoring and management.
The Rapid fFN® 10Q test represents a significant and necessary improvement in the ability to manage preterm labour that can lead to preterm birth. It offers a reliable and rapid solution for healthcare professionals, enabling better management of at-risk patients. By providing accurate quantitative results, this test enables doctors to make informed decisions about patient management, reducing the risk of preterm birth and improving outcomes for both mother and baby.
The Rapid fFN® 10Q is simple and effective to use, with a fast turnaround time , enabling rapid and appropriate intervention. This test is an essential tool in modern clinical practice, offering a reliable solution for assessing the risk of preterm labour and improving the management of at-risk patients. By incorporating this test into prenatal care protocols, healthcare professionals can provide better care for patients, thereby reducing complications associated with preterm labour.
